CAC
SCPE

Cowen and Company’s SC Health Corporation SCPE Stock Holding History

Cowen and Company’s Portfolio SCPE Stock Details SCPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-157,664
Closed -$1.55M – 651
2019
Q3 		$1.55M Buy
+157,664
New +$1.56M 0.39% 42

Other funds holding SCPE

RIA
RP Investment Advisors Toronto, Ontario, Canada $900K AUM 17.98% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
SRCM
Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

Cowen and Company's SCPE Position: Q4 2019 in Review

Cowen and Company sold out of SC Health Corporation (SCPE) in Q4 2019, closing a stake of 157,664 shares — an estimated $1.55M sold.

Cowen and Company first reported a position in SCPE in Q3 2019 and held it in 1 quarter. The position peaked at $1.55M in Q3 2019. 21 funds tracked by Wall St. Rank hold SCPE as of Q4 2019.

  • Cowen and Company reported no remaining SC Health Corporation position as of Q4 2019 after selling out during the quarter.
  • Cowen and Company sold 157,664 SC Health Corporation shares in Q4 2019, an estimated $1.55M.
  • Cowen and Company first reported a position in SC Health Corporation in Q3 2019 and held it in 1 quarter.
  • Cowen and Company's SC Health Corporation position peaked at $1.55M in Q3 2019.
  • 21 funds tracked by Wall St. Rank held SC Health Corporation as of Q4 2019.

Based on Cowen and Company's 13F filing for Q4 2019, filed 11 Feb 2020.